Novo Nordisk Aktie - NOV

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

85,56

Gebot

85,56

Fragen

85,56

Volumen

0,00

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

384,679B

Handelsende

85,56

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

4.496.011.436

Dividendenrendite

86.69%

Kurs-Gewinn-Verhältnis

4,65

Gewinn pro Aktie (EPS)

18,61

Erlöse

232,26B

Nettogewinn

83,68B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.novonordisk.com

Hauptsitz

Bagsvaerd, Dnk

Gegründet

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 85,56 €. Over the last year, Novo Nordisk shares have traded in a share price range of 0,00 € to 0,00 €.

Novo Nordisk currently has 4.496.011.436 shares in issue. The market capitalisation of Novo Nordisk is 384,68 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.65.

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced...

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed Bagsværd, Denmark, 18 December 2024 — Today...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to...

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close Bagsværd, Denmark...

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events Bagsværd, Denmark, 12...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 9 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings Bagsværd, Denmark, 6...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 2 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

NOV - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?

The current share price of Novo Nordisk is 85,56 €

How many Novo Nordisk shares are in issue?

Novo Nordisk has 4.496.011.436 shares in issue

What is the market cap of Novo Nordisk?

The market capitalisation of Novo Nordisk is EUR 384,68B

What is the 1 year trading range for Novo Nordisk share price?

Novo Nordisk has traded in the range of 0,00 € to 0,00 € during the past year

What is the PE ratio of Novo Nordisk?

The price to earnings ratio of Novo Nordisk is 4,65

What is the cash to sales ratio of Novo Nordisk?

The cash to sales ratio of Novo Nordisk is 1,68

What is the reporting currency for Novo Nordisk?

Novo Nordisk reports financial results in DKK

What is the latest annual turnover for Novo Nordisk?

The latest annual turnover of Novo Nordisk is DKK 232,26B

What is the latest annual profit for Novo Nordisk?

The latest annual profit of Novo Nordisk is DKK 83,68B

What is the registered address of Novo Nordisk?

The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880

What is the Novo Nordisk website address?

The website address for Novo Nordisk is www.novonordisk.com

Which industry sector does Novo Nordisk operate in?

Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
0RARAPT Therapeutics Inc	1,61 € (101,25%)	83,81k
KASHIntellabridge Technology Corp	0,047 € (88,00%)	1,24M
4APApollo Minerals Ltd	0,01 € (66,67%)	30
AWY0Percheron Therapeutics Ltd	0,007 € (55,56%)	660k
1W81WISeKey International Holding Ltd	9,70 € (44,78%)	4,81k
013CJDcom Inc	17,426 € (0,00%)	0
013AJD.com Inc	34,90 € (0,00%)	0
0110Thesis Gold Inc	0,391 € (0,00%)	0
00WAspermont Ltd	0,004 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0
D7GNel ASA	0,2496 € (-0,79%)	3,89M
RQ0DWave Quantum Inc	7,896 € (24,07%)	2,16M
FWR0Yumy Candy Company Inc the	0,0352 € (40,80%)	2,12M
PF8European Lithium Limited	0,0204 € (-0,97%)	2,07M
DI6Distribuidora Internacional De Alimentacion SA	0,017 € (1,80%)	1,83M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOV)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Novo Nordisk

NOV Neueste Nachrichten

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

Novo Nordisk A/S - share repurchase programme

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

Novo Nordisk A/S - share repurchase programme

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

Novo Nordisk A/S - share repurchase programme

NOV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOV) Börsenkurse

Novo Nordisk (NOV)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Novo Nordisk

NOV Neueste Nachrichten

NOV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE